Holdings
Mpm Bioimpact LLC
As of Jun 30, 2026, Mpm Bioimpact LLC reported 32 positions worth US$1.47B. Largest: Cullinan Therapeutics, Inc., Aktis Oncology, Inc. and Liquidia Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 9.73M | US$177M | +2.08M | Jun 30, 2026 |
| Aktis Oncology, Inc. | 4.84M | US$156M | no change | Jun 30, 2026 |
| Liquidia Corporation | 1.39M | US$111M | −18,984 | Jun 30, 2026 |
| Revolution Medicines, Inc. | 492K | US$92.2M | −14,293 | Jun 30, 2026 |
| Corcept Therapeutics Incorporated | 771K | US$67M | −215K | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 1.62M | US$65.9M | −39,916 | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 1.12M | US$63.8M | −10,634 | Jun 30, 2026 |
| Dbv Technologies Sa | 3.67M | US$60.1M | −1.55M | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 3.07M | US$57.3M | −225K | Jun 30, 2026 |
| Alumis Inc. | 2.02M | US$56.8M | −368K | Jun 30, 2026 |